Who are Tuberculin purified protein derivative's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Aplisol.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/tuberculin-purified-protein-derivative.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Tuberculin purified protein derivative — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tuberculin purified protein derivative (Tuberculin purified protein derivative) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Skin Test Antigen [EPC].

marketed Skin Test Antigen [EPC] Biologic Live · refreshed every 30 min

Target snapshot

Tuberculin purified protein derivative (Tuberculin purified protein derivative) — Assiut University.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Tuberculin purified protein derivative TARGET	Tuberculin purified protein derivative	Assiut University	marketed	Skin Test Antigen [EPC]
Aplisol	TUBERCULIN	ENDO USA, Inc.	marketed	Skin Test Antigen [EPC]

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Skin Test Antigen [EPC] class)

Assiut University · 1 drug in this class
ENDO USA, Inc. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Tuberculin purified protein derivative — Competitive Intelligence Brief. https://druglandscape.com/ci/tuberculin-purified-protein-derivative. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab